Recent studies into retatritide peptide highlight promising possibility for treating weight and type 2 diabetes. The compound, a dual stimulator of GLP-1 receptor and glucose-dependent insulinotropic polypeptide, looks to offer greater weight reduction and glucose control compared existing therapies. Ongoing clinical trials are necessary to fully e